Patents by Inventor Peter David Gluckman

Peter David Gluckman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neuronal rescue agent
    Publication number: 20030060398
    Abstract: This invention includes embodiments comprising activin and analogs of activin for neuronal rescue in patients having neurons that are subject to death and/or degradation as a result of neurological diseases. In certain embodiments, an activin receptor agonist can be useful for treating neuralogical diseases such as Alzheimer's Disease, Parkinson's Disease or other diseases involving neural degeneration and loss of neural function.
    Type: Application
    Filed: May 28, 2002
    Publication date: March 27, 2003
    Inventors: Peter David Gluckman, Christopher Edward Williams, Dahao Wu, Paul Edmund Hughes, Maggie Lai
  • Composition and methods to improve neural outcome
    Publication number: 20030027760
    Abstract: A method for protecting white matter, axons, and oligodendrocytes of a mammal, especially a human, against degeneration and death resulting from multiple sclerosis or periventricular leucomalacia by increasing the effective concentration of a GPE-related compound in the central nervous system of the mammal. This increase may be achieved by administration to the mammal of an effective amount of a GPE-related compound, a prodrug thereof, or an implant containing cells that express the GPE-related compound or prodrug.
    Type: Application
    Filed: April 8, 2002
    Publication date: February 6, 2003
    Inventors: Peter David Gluckman, Ernest S. Sirimanne, Geoffrey W. Krissansen, Jagat R. Kanwar
  • Method of treating hypertension in pregnant mammals
    Patent number: 5922673
    Abstract: A method of treating a pregnant mammal (including a human) which comprises administering IGF-1 or an analogue thereof or another hormone (such as growth hormone) which elevates maternal IGF-1 to thereby illicit a reduction of material blood pressure and/or to promote fetal growth and placental function.
    Type: Grant
    Filed: May 28, 1997
    Date of Patent: July 13, 1999
    Assignee: Chiron Corporation
    Inventors: Peter David Gluckman, Barbara Madeleine Johnston, Nicole Susan Bassett
  • Fetal growth
    Patent number: 5858966
    Abstract: A method of enhancing fetal growth and/or development and/or neonatal survival by the administration over a period of insulin-like growth factor (IGF-1), to either the amniotic fluid or direct to the fetal gastrointestinal tract. Administration may be by way of an ultrasonically monitored injection or placement of a catheter.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: January 12, 1999
    Assignee: Auckland UniServices Limited
    Inventors: Jane Elizabeth Harding, Roy Mark Kimble, Peter David Gluckman
  • Use of growth factor IGF-I and/or IGF-II
    Patent number: 5710127
    Abstract: The present invention relates to a composition comprising exogenous human or animal IGF-I or IGF-II or both or effective analogs thereof comprising foodstuff for oral administration wherein the foodstuff is selected from the group consisting of artificial milk, natural milk and colostrum.
    Type: Grant
    Filed: March 7, 1996
    Date of Patent: January 20, 1998
    Assignee: Pharmacia & Upjohn Aktiebolag
    Inventors: Peter David Gluckman, David James Mellor